Renaissance Capital LLC - LEGEND BIOTECH CORP ownership

LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 161 filers reported holding LEGEND BIOTECH CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.

Quarter-by-quarter ownership
Renaissance Capital LLC ownership history of LEGEND BIOTECH CORP
ValueSharesWeighting
Q1 2023$882,426
-12.7%
18,300
-9.7%
0.65%
-17.2%
Q4 2022$1,011,279
+22.0%
20,258
-0.3%
0.79%
+48.3%
Q3 2022$829,000
+35.0%
20,318
+82.0%
0.53%
+62.7%
Q2 2022$614,000
+124.9%
11,163
+48.5%
0.33%
+181.9%
Q1 2022$273,000
-38.4%
7,516
-20.8%
0.12%
+1.8%
Q4 2021$443,0009,4950.11%
Other shareholders
LEGEND BIOTECH CORP shareholders Q1 2023
NameSharesValueWeighting ↓
FengHe Fund Management Pte. Ltd. 997,714$36,257,00013.28%
JOHNSON & JOHNSON 1,629,173$59,204,00011.19%
Paradigm Biocapital Advisors LP 831,728$30,225,0007.99%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,100,542$39,994,0005.54%
HHLR ADVISORS, LTD. 6,936,617$252,077,0005.26%
Old Well Partners, LLC 79,700$2,896,0001.94%
Parkman Healthcare Partners LLC 120,473$4,378,0001.28%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 4,500$5,632,0001.27%
AtonRa Partners 50,928$1,851,0001.00%
Avidity Partners Management LP 1,095,000$39,792,0000.83%
View complete list of LEGEND BIOTECH CORP shareholders